A $10 BILLION PIE
New drugs, spin on old ones aim for piece of ADHD market
By Brian Orelli
Monday, July 14, 2014
The attention deficit hyperactivity disorder (ADHD) market is $10 billion strong, but grabbing a piece of the pie with so many drugs already on the market, including some generics, requires differentiation.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.